FAPα is a type II cell surface serine protease with dipeptidylpeptidase and endopeptidase activity [44] that is overexpressed in activated fibroblasts, such as those involved in cancer and fibrosis; the expression of FAPα in healthy tissues is scarce, making FAPα an attractive therapeutic target in disease [45]. Here, FAP is linked to cancer.